After 12 months, researchers found that the device was associated with control of AFib in 99% of patients and relief from AFib symptoms in 93.1% of patients.
Could this late-breaking clinical trial from TCT 2023 be a sign of things to come in the years ahead? Samir Kapadia, MD, explored the topic in a new interview.
Lawrence Faucette. Image courtesy of the University of Maryland Medical Center.
Lawrence Faucette, the second patient to ever receive a genetically modified pig heart, died on Oct. 30. “He can never be forgotten," his wife said in a statement.
Intravascular lithotripsy therapy to break up calcified coronary lesions will now be reimbursed at a higher rate under new in-hospital codes the went into effect Oct. 1.
APG sends a low intensity ultrasound transmitting wave (TX wave) using an ANC headphone's speakers and collects the receiving wave (RX wave) via the on-board feedback microphones. The APG signal is a pulse-like waveform that synchronizes with heartbeat and reveals rich cardiac information. Image and caption courtesy of Google.
The new technique, audioplethysmography, can monitor a user’s heart rate and other physiological signals using headphones equipped with active noice canceling technology. It requires no additional sensors.
A cardiologist-led think tank tracked data from more than 1 million procedures, exploring the clinical and economic impacts of implanting low-value coronary stents.
Robert Yeh, MD, detailed the importance of the pivotal AGENT IDE trial, which focused on the use of a paclitaxel-coated balloon to treat in-stent restenosis.
